| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss before income taxes | -135 | 0 | -112 | -92 |
| Income tax expense | 0 | 0 | - | - |
| Net loss | -135 | 0 | -112 | -92 |
| Basic (in dollars per share) | -1.27 | 0 | -1.14 | -1 |
| Basic (in shares) | 106,500,000 | 106,100,000 | 98,400,000 | 91,400,000 |
| Diluted (in dollars per share) | -1.27 | 0 | -1.14 | -1 |
| Diluted (in shares) | 106,500,000 | 106,500,000 | 98,400,000 | 91,400,000 |
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. (RCUS)